Summary
Personalised phage therapy using magistral preparations of phages is among the most promising solutions to fight antimicrobial resistant infections, but this approach requires a rapid diagnostic that identifies the pathogen(s) involved in the infection and the phages active on them. Vésale Bioscience has developed the “Phagogram”, the first automated in-vitro diagnostic tool that enables a fast determination of bacteriophages suitable for treating a particular bacterial infection. It consists of a basic test kit (a disposable well plate with reagents), a high-performance luminometer and a dedicated software that proposes the best matching phage cocktail to treat the patient. Compared to the current diagnostic methodologies, which take up to 4-7 days, the Phagogram compares the activity of up to 96 phages on a bacterial culture within 2-3 hours, making phage susceptibility testing accessible for hospital microbiology labs and enabling personalized therapy on a routine basis.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: | https://cordis.europa.eu/project/id/190150004 |
Start date: | 01-02-2023 |
End date: | 31-01-2025 |
Total budget - Public funding: | 3 104 962,50 Euro - 1 800 000,00 Euro |
Cordis data
Original description
Personalised phage therapy using magistral preparations of phages is among the most promising solutions to fight antimicrobial resistant infections, but this approach requires a rapid diagnostic that identifies the pathogen(s) involved in the infection and the phages active on them. Vésale Bioscience has developed the “Phagogram”, the first automated in-vitro diagnostic tool that enables a fast determination of bacteriophages suitable for treating a particular bacterial infection. It consists of a basic test kit (a disposable well plate with reagents), a high-performance luminometer and a dedicated software that proposes the best matching phage cocktail to treat the patient. Compared to the current diagnostic methodologies, which take up to 4-7 days, the Phagogram compares the activity of up to 96 phages on a bacterial culture within 2-3 hours, making phage susceptibility testing accessible for hospital microbiology labs and enabling personalized therapy on a routine basis.Status
SIGNEDCall topic
HORIZON-EIC-2022-ACCELERATOROPEN-01Update Date
31-07-2023
Images
No images available.
Geographical location(s)